EXCLUSIVE: Co-Diagnostics Expands South Asia Reach, Targets $13 Billion Market Opportunity

CoSara is the Indian joint venture between Co-Dx and Ambalal Sarabhai Enterprises Limited.Co-Diagnostics, most recently, regained NASDAQ listing compliance.Territory Expansion Unlocks $13 Billion Market OpportunityThe expansion significantly increases CoSara's addressable market across South Asia, bringing the total regional opportunity to an estimated $13 billion based on internal analyses and third-party market data.It also supports CoSara's plans to commercialize the CoSara PCR Pro point-of-care instrume ...